News | June 14, 2024
Suven to acquire a majority stake in CDMO player ‘Sapala Organics’
Sapala has a strong customer base including innovator Pharma, CDMOs & diagnostic companies
Sapala has a strong customer base including innovator Pharma, CDMOs & diagnostic companies
The primary endpoint in the final analysis was assessed by change in the North Star Ambulatory Assessment at one year after treatment
Glenmark's current portfolio consists of 197 products authorized for distribution in the U.S. marketplace
Prior to taking charge at the Union Health Ministry, Jadhav planted a sapling at his residence
DurA Cycle is designed for large-scale commercial manufacturing of monoclonal antibodies,
Innovative technologies and comprehensive services to strengthen Syntegon’s strategic growth
Ashkenazi will continue to serve at full capacity in her role and as a member of Lilly's Executive Committee through July 2024
The Gavi Board today approved the Vaccine Alliance's strategy for the five-year period running from 2026 to 2030
Oligonucleotides are a unique modality with potential to address hard-to-treat diseases with high unmet need
The transaction aligns with Lupin's strategy to grow its global presence in Specialty areas
Subscribe To Our Newsletter & Stay Updated
